Top Markets
Coin of the day
Crossject Société Anonyme Crossject Société Anonyme

Crossject Société Anonyme

ALCJ
Classifica tra le azioni #12721
Crossject Société Anonyme develops needle-free injection systems. The company... Crossject Société Anonyme develops needle-free injection systems. The company develops ZENEO, a needle-free, prefilled, and single-use auto-injector. Its clinical stage drugs comprise Sumatriptan, which is used for of treatment migraines and cluster headaches; Adrenaline for treating anaphylactic shock; Hydrocortisone that is used for treatment of acute adrenal crisis; Midazolam for treating epileptic seizure; Naloxone used for treatment of overdose; Apomorphine, for treating temporary paralysis in parkinson's disease; Methotrexate used for treatment of rheumatoid arthritis; and Terbutaline, for treating severe asthma crisis. The company was founded in 1997 and is based in Dijon, France.
Prezzo delle azioni
$2.03
Capitalizzazione di mercato
$121.44M
Variazione (1 giorno)
-0.93%
Variazione (1 anno)
-1.97%
Paese
FR
Scambia Crossject Société Anonyme (ALCJ)

Categoria

EPS per Crossject Société Anonyme (ALCJ)
EPS al December 2025 TTM: $-0.25
Secondo gli ultimi rapporti finanziari e il prezzo delle azioni di Crossject Société Anonyme, l’EPS attuale della società (TTM) è $-0.25. Alla fine del 2023, la società aveva un EPS di $-0.25 una diminuzione rispetto a rispetto a quello del 2022, che era di $-0.33.
Storico EPS per Crossject Société Anonyme da 2010 a 2026
EPS alla fine di ogni anno
Anno EPS Cambia
2026 (TTM) $-0.25 -15.03%
2024 $-0.29 14.59%
2023 $-0.25 -23.52%
2022 $-0.33 -30.38%
2021 $-0.48 -4.35%
2020 $-0.50 23.62%
2019 $-0.40 -55.51%
2018 $-0.91 -8.85%
2017 $-1.00 7.56%
2016 $-0.93 5.28%
2015 $-0.88 11.82%
2014 $-0.79 68.20%
2013 $-0.47 68.81%
2012 $-0.28 -161.13%
2011 $0.45 -136.44%
2010 $-1.24 0.00%
EPS per aziende simili o concorrenti
Azienda EPS Differenza di EPS Il paese
$8.37 -3,496.92%
US
$5.91 -2,499.88%
FR
$0.56 -326.26%
DE
$4.93 -2,102.39%
JP
$3.95 -1,703.08%
US